InsidersTradesSigma
Follow the Solid Biosciences Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Solid Biosciences Inc. has logged 96 insider filings. Market capitalisation: €776.8m. The latest transaction was filed on 7 July 2026 (Levée d'options). Among the most active insiders: SMITH IAN F. Every trade is openly available.
96
Insider Decl.
n/a
Thresholds
€47m
7 ops.
Buy Volume
€756,292
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Solid Biosciences Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$17.50.
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,002 of 29,055 companies
22.4
score / 100
Value12
Quality33
FCF yld-15%
Earn yld-17%
EV/EBITDA·
ROE-66%
Gross mgn43%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
Declarations96 total
3,440 sharesCommon StockSEC:0001193125-26-297456:0
3,441 sharesCommon StockSEC:0001193125-26-140056:0
30,031 sharesCommon StockSEC:0001193125-26-057878:0
8,125 sharesCommon StockSEC:0001193125-26-057872:0
4,861 sharesCommon StockSEC:0001193125-26-057868:0
7,187 sharesCommon StockSEC:0001193125-26-057865:0
14,687 sharesCommon StockSEC:0001193125-26-057863:0
10,937 sharesCommon StockSEC:0001193125-26-057859:0
18,894 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041523:0
48,913 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041519:0
7,205 shares@ US$6.441976.4% of flowCommon StockSEC:0001193125-26-041516:0
12,616 shares@ US$6.441968.0% of flowCommon StockSEC:0001193125-26-041511:0
12,348 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041507:0
10,905 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041506:0
79,341 sharesCommon StockSEC:0001193125-26-034080:0
54,925 sharesCommon StockSEC:0001193125-26-034076:0
15,000 sharesCommon StockSEC:0001193125-26-034072:0
169,401 sharesCommon StockSEC:0001193125-26-034087:0
54,925 sharesCommon StockSEC:0001193125-26-034085:0
58,847 sharesCommon StockSEC:0001193125-26-034083:0
389 sharesCommon StockSEC:0001193125-26-031765:0
25 of 96 declarations
关于 Solid Biosciences Inc.
Solid Biosciences Inc. 是一家生物制药公司，专注于开发罕见遗传疾病，特别是杜氏肌营养不良症的治疗方法。该公司在纳斯达克上市，股票代码为 SLDB。